Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Residual Sleepiness in OSA
NCT03299257Phase 4Unknown
- Sponsor
- AFIP
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in obstructive sleep apnea (OSA), sponsored by AFIP. Status: unknown.
02
Drugs
donepezil
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03299257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299257.